Pharmacodynamic model of the haemodynamic effects of pinacidil in normotensive volunteers View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1993-03

AUTHORS

P. Girard, J. L. Saumet, F. Dubois, J. P. Boissel

ABSTRACT

The concentration-effect relationships of pinacidil, a peripheral vasodilator, have been measured in 12 healthy adults who received placebo or pinacidil 25 mg daily for 1 week in a cross-over experiment. Diastolic blood pressure (DBP) and heart rate (HR) were recorded and blood samples were taken on days 1 and 7. Plasma drug concentration-time data were fitted by a biexponential function with zero-order input. The pharmacokinetic model was incorporated into a combined pharmacokinetic-dynamic model (PK-PD) using the Hill equation, which has three parameters: n, the sigmoidicity parameter, Emax the maximum effect and EC50 the concentration which gives 50% of Emax. For ΔDBP, the parameter medians were estimated as n=5, EC50=44.6 ng · ml−1 and Emax=13.5 mm Hg.A hysteresis loop was found when ΔHR was plotted against concentration, which could be fitted by a linear effect compartment model. Simulations showed that experimental ΔDBP points on Day 7 could be predicted from a simulated curve computed by the model using parameters estimated on Day 1.Using the simulation, it was possible to suggest an optimal dosage regimen for pinacidil tablets. More... »

PAGES

177-182

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/bf00315477

DOI

http://dx.doi.org/10.1007/bf00315477

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1041960347

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/8453963


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antihypertensive Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Pressure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Computer Simulation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Double-Blind Method", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Guanidines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Heart Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hemodynamics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pinacidil", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Potassium Channels", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Unit\u00e9 de Pharmacologie Clinique, Lyon, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "INSERM, Lyon, France", 
            "Unit\u00e9 de Pharmacologie Clinique, Lyon, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Girard", 
        "givenName": "P.", 
        "id": "sg:person.012661201622.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012661201622.56"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Unit\u00e9 de Pharmacologie Clinique, Lyon, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Unit\u00e9 de Pharmacologie Clinique, Lyon, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Saumet", 
        "givenName": "J. L.", 
        "id": "sg:person.01345072722.90", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01345072722.90"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Unit\u00e9 de Pharmacologie Clinique, Lyon, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Unit\u00e9 de Pharmacologie Clinique, Lyon, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dubois", 
        "givenName": "F.", 
        "id": "sg:person.01056542766.95", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01056542766.95"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Unit\u00e9 de Pharmacologie Clinique, Lyon, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Unit\u00e9 de Pharmacologie Clinique, Lyon, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Boissel", 
        "givenName": "J. P.", 
        "id": "sg:person.01166704464.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01166704464.31"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf00542128", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048586909", 
          "https://doi.org/10.1007/bf00542128"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/clpt.1987.107", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042716098", 
          "https://doi.org/10.1038/clpt.1987.107"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00543493", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043833646", 
          "https://doi.org/10.1007/bf00543493"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/clpt.1985.36", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048464171", 
          "https://doi.org/10.1038/clpt.1985.36"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00637672", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031035399", 
          "https://doi.org/10.1007/bf00637672"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/clpt.1986.35", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052298210", 
          "https://doi.org/10.1038/clpt.1986.35"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00003088-198106060-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024854213", 
          "https://doi.org/10.2165/00003088-198106060-00002"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/clpt.1984.104", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051299306", 
          "https://doi.org/10.1038/clpt.1984.104"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf03036252", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050707722", 
          "https://doi.org/10.1007/bf03036252"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1993-03", 
    "datePublishedReg": "1993-03-01", 
    "description": "The concentration-effect relationships of pinacidil, a peripheral vasodilator, have been measured in 12 healthy adults who received placebo or pinacidil 25 mg daily for 1 week in a cross-over experiment. Diastolic blood pressure (DBP) and heart rate (HR) were recorded and blood samples were taken on days 1 and 7. Plasma drug concentration-time data were fitted by a biexponential function with zero-order input. The pharmacokinetic model was incorporated into a combined pharmacokinetic-dynamic model (PK-PD) using the Hill equation, which has three parameters: n, the sigmoidicity parameter, Emax the maximum effect and EC50 the concentration which gives 50% of Emax. For \u0394DBP, the parameter medians were estimated as n=5, EC50=44.6 ng \u00b7 ml\u22121 and Emax=13.5 mm Hg.A hysteresis loop was found when \u0394HR was plotted against concentration, which could be fitted by a linear effect compartment model. Simulations showed that experimental \u0394DBP points on Day 7 could be predicted from a simulated curve computed by the model using parameters estimated on Day 1.Using the simulation, it was possible to suggest an optimal dosage regimen for pinacidil tablets.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/bf00315477", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1054337", 
        "issn": [
          "0031-6970", 
          "1432-1041"
        ], 
        "name": "European Journal of Clinical Pharmacology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "44"
      }
    ], 
    "keywords": [
      "diastolic blood pressure", 
      "heart rate", 
      "plasma drug concentration-time data", 
      "optimal dosage regimen", 
      "drug concentration-time data", 
      "pharmacokinetic-dynamic model", 
      "concentration-effect relationship", 
      "effect compartment model", 
      "concentration-time data", 
      "zero-order input", 
      "haemodynamic effects", 
      "normotensive volunteers", 
      "peripheral vasodilator", 
      "blood pressure", 
      "dosage regimen", 
      "blood samples", 
      "day 1", 
      "healthy adults", 
      "day 7", 
      "pharmacodynamic model", 
      "cross-over experiment", 
      "pharmacokinetic model", 
      "pinacidil", 
      "maximum effect", 
      "parameter medians", 
      "Emax", 
      "compartment model", 
      "placebo", 
      "\u0394DBP", 
      "vasodilators", 
      "regimen", 
      "biexponential function", 
      "daily", 
      "weeks", 
      "volunteers", 
      "median", 
      "adults", 
      "EC50", 
      "Hg", 
      "effect", 
      "\u0394HR", 
      "concentration", 
      "tablets", 
      "Hill equation", 
      "rate", 
      "pressure", 
      "function", 
      "samples", 
      "data", 
      "model", 
      "relationship", 
      "curves", 
      "parameters", 
      "point", 
      "loop", 
      "experiments", 
      "input", 
      "simulations", 
      "hysteresis loops", 
      "equations"
    ], 
    "name": "Pharmacodynamic model of the haemodynamic effects of pinacidil in normotensive volunteers", 
    "pagination": "177-182", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1041960347"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/bf00315477"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "8453963"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/bf00315477", 
      "https://app.dimensions.ai/details/publication/pub.1041960347"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:28", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_222.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/bf00315477"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf00315477'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf00315477'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf00315477'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf00315477'


 

This table displays all metadata directly associated to this object as RDF triples.

227 TRIPLES      21 PREDICATES      107 URIs      90 LITERALS      19 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/bf00315477 schema:about N05e34fe156da46f487efa1b9f62bc5bb
2 N100c6dfa783e4d248a500b8cf9225a94
3 N18e898453c08401495cf5f00fa1021a0
4 N4ae1b17e332342938ffecca3ecac20b0
5 N4f323ca8b74a4d01b1ee048ffb583f33
6 N58ad5d83d1394c418b28743899f82d87
7 N6c845623d66c4186b98516e6606e1fb3
8 N830b1e124b6b4c799702245a232c93a9
9 N8c19ebc9be0f47279e515ce3bf652ef2
10 Nabadc3ac1d9340b18ff1a9bd800397c0
11 Ncafd97634a524e808ff2fe3124a86292
12 Nf45f2075289243208c448f680aae78d6
13 anzsrc-for:11
14 anzsrc-for:1117
15 schema:author N7e0f5978a1474eb59746328c7f7bf798
16 schema:citation sg:pub.10.1007/bf00542128
17 sg:pub.10.1007/bf00543493
18 sg:pub.10.1007/bf00637672
19 sg:pub.10.1007/bf03036252
20 sg:pub.10.1038/clpt.1984.104
21 sg:pub.10.1038/clpt.1985.36
22 sg:pub.10.1038/clpt.1986.35
23 sg:pub.10.1038/clpt.1987.107
24 sg:pub.10.2165/00003088-198106060-00002
25 schema:datePublished 1993-03
26 schema:datePublishedReg 1993-03-01
27 schema:description The concentration-effect relationships of pinacidil, a peripheral vasodilator, have been measured in 12 healthy adults who received placebo or pinacidil 25 mg daily for 1 week in a cross-over experiment. Diastolic blood pressure (DBP) and heart rate (HR) were recorded and blood samples were taken on days 1 and 7. Plasma drug concentration-time data were fitted by a biexponential function with zero-order input. The pharmacokinetic model was incorporated into a combined pharmacokinetic-dynamic model (PK-PD) using the Hill equation, which has three parameters: n, the sigmoidicity parameter, Emax the maximum effect and EC50 the concentration which gives 50% of Emax. For ΔDBP, the parameter medians were estimated as n=5, EC50=44.6 ng · ml−1 and Emax=13.5 mm Hg.A hysteresis loop was found when ΔHR was plotted against concentration, which could be fitted by a linear effect compartment model. Simulations showed that experimental ΔDBP points on Day 7 could be predicted from a simulated curve computed by the model using parameters estimated on Day 1.Using the simulation, it was possible to suggest an optimal dosage regimen for pinacidil tablets.
28 schema:genre article
29 schema:isAccessibleForFree false
30 schema:isPartOf N4688b30c75d24d2fa08e4d24c3a6ef7d
31 N6660381ae71d4ab8a740454e2566ff7b
32 sg:journal.1054337
33 schema:keywords EC50
34 Emax
35 Hg
36 Hill equation
37 adults
38 biexponential function
39 blood pressure
40 blood samples
41 compartment model
42 concentration
43 concentration-effect relationship
44 concentration-time data
45 cross-over experiment
46 curves
47 daily
48 data
49 day 1
50 day 7
51 diastolic blood pressure
52 dosage regimen
53 drug concentration-time data
54 effect
55 effect compartment model
56 equations
57 experiments
58 function
59 haemodynamic effects
60 healthy adults
61 heart rate
62 hysteresis loops
63 input
64 loop
65 maximum effect
66 median
67 model
68 normotensive volunteers
69 optimal dosage regimen
70 parameter medians
71 parameters
72 peripheral vasodilator
73 pharmacodynamic model
74 pharmacokinetic model
75 pharmacokinetic-dynamic model
76 pinacidil
77 placebo
78 plasma drug concentration-time data
79 point
80 pressure
81 rate
82 regimen
83 relationship
84 samples
85 simulations
86 tablets
87 vasodilators
88 volunteers
89 weeks
90 zero-order input
91 ΔDBP
92 ΔHR
93 schema:name Pharmacodynamic model of the haemodynamic effects of pinacidil in normotensive volunteers
94 schema:pagination 177-182
95 schema:productId N3c016b59cb4c436789879d96a63e0bc8
96 N64b93d2759e0489dbe65e3ca5e880a31
97 Na35aaa616f29442da1fdfe13d953051f
98 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041960347
99 https://doi.org/10.1007/bf00315477
100 schema:sdDatePublished 2022-10-01T06:28
101 schema:sdLicense https://scigraph.springernature.com/explorer/license/
102 schema:sdPublisher N3d69456227574a6e944f140da01e2d07
103 schema:url https://doi.org/10.1007/bf00315477
104 sgo:license sg:explorer/license/
105 sgo:sdDataset articles
106 rdf:type schema:ScholarlyArticle
107 N05e34fe156da46f487efa1b9f62bc5bb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Guanidines
109 rdf:type schema:DefinedTerm
110 N100c6dfa783e4d248a500b8cf9225a94 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Humans
112 rdf:type schema:DefinedTerm
113 N18e898453c08401495cf5f00fa1021a0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Antihypertensive Agents
115 rdf:type schema:DefinedTerm
116 N3c016b59cb4c436789879d96a63e0bc8 schema:name doi
117 schema:value 10.1007/bf00315477
118 rdf:type schema:PropertyValue
119 N3d69456227574a6e944f140da01e2d07 schema:name Springer Nature - SN SciGraph project
120 rdf:type schema:Organization
121 N4688b30c75d24d2fa08e4d24c3a6ef7d schema:issueNumber 2
122 rdf:type schema:PublicationIssue
123 N4ae1b17e332342938ffecca3ecac20b0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Double-Blind Method
125 rdf:type schema:DefinedTerm
126 N4f323ca8b74a4d01b1ee048ffb583f33 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Potassium Channels
128 rdf:type schema:DefinedTerm
129 N58ad5d83d1394c418b28743899f82d87 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Blood Pressure
131 rdf:type schema:DefinedTerm
132 N64b93d2759e0489dbe65e3ca5e880a31 schema:name pubmed_id
133 schema:value 8453963
134 rdf:type schema:PropertyValue
135 N6660381ae71d4ab8a740454e2566ff7b schema:volumeNumber 44
136 rdf:type schema:PublicationVolume
137 N6c845623d66c4186b98516e6606e1fb3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Adult
139 rdf:type schema:DefinedTerm
140 N7e0f5978a1474eb59746328c7f7bf798 rdf:first sg:person.012661201622.56
141 rdf:rest Naebd1d29ae4a4f8296c1ed7bbfa309c3
142 N830b1e124b6b4c799702245a232c93a9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Male
144 rdf:type schema:DefinedTerm
145 N8c19ebc9be0f47279e515ce3bf652ef2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Pinacidil
147 rdf:type schema:DefinedTerm
148 Na35aaa616f29442da1fdfe13d953051f schema:name dimensions_id
149 schema:value pub.1041960347
150 rdf:type schema:PropertyValue
151 Nabadc3ac1d9340b18ff1a9bd800397c0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Heart Rate
153 rdf:type schema:DefinedTerm
154 Naebd1d29ae4a4f8296c1ed7bbfa309c3 rdf:first sg:person.01345072722.90
155 rdf:rest Nbe8154d9b22b4c688904aabef8baf2d3
156 Nbe8154d9b22b4c688904aabef8baf2d3 rdf:first sg:person.01056542766.95
157 rdf:rest Neb35b51096a44694975649f131782fff
158 Ncafd97634a524e808ff2fe3124a86292 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Computer Simulation
160 rdf:type schema:DefinedTerm
161 Neb35b51096a44694975649f131782fff rdf:first sg:person.01166704464.31
162 rdf:rest rdf:nil
163 Nf45f2075289243208c448f680aae78d6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Hemodynamics
165 rdf:type schema:DefinedTerm
166 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
167 schema:name Medical and Health Sciences
168 rdf:type schema:DefinedTerm
169 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
170 schema:name Public Health and Health Services
171 rdf:type schema:DefinedTerm
172 sg:journal.1054337 schema:issn 0031-6970
173 1432-1041
174 schema:name European Journal of Clinical Pharmacology
175 schema:publisher Springer Nature
176 rdf:type schema:Periodical
177 sg:person.01056542766.95 schema:affiliation grid-institutes:None
178 schema:familyName Dubois
179 schema:givenName F.
180 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01056542766.95
181 rdf:type schema:Person
182 sg:person.01166704464.31 schema:affiliation grid-institutes:None
183 schema:familyName Boissel
184 schema:givenName J. P.
185 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01166704464.31
186 rdf:type schema:Person
187 sg:person.012661201622.56 schema:affiliation grid-institutes:None
188 schema:familyName Girard
189 schema:givenName P.
190 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012661201622.56
191 rdf:type schema:Person
192 sg:person.01345072722.90 schema:affiliation grid-institutes:None
193 schema:familyName Saumet
194 schema:givenName J. L.
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01345072722.90
196 rdf:type schema:Person
197 sg:pub.10.1007/bf00542128 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048586909
198 https://doi.org/10.1007/bf00542128
199 rdf:type schema:CreativeWork
200 sg:pub.10.1007/bf00543493 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043833646
201 https://doi.org/10.1007/bf00543493
202 rdf:type schema:CreativeWork
203 sg:pub.10.1007/bf00637672 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031035399
204 https://doi.org/10.1007/bf00637672
205 rdf:type schema:CreativeWork
206 sg:pub.10.1007/bf03036252 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050707722
207 https://doi.org/10.1007/bf03036252
208 rdf:type schema:CreativeWork
209 sg:pub.10.1038/clpt.1984.104 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051299306
210 https://doi.org/10.1038/clpt.1984.104
211 rdf:type schema:CreativeWork
212 sg:pub.10.1038/clpt.1985.36 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048464171
213 https://doi.org/10.1038/clpt.1985.36
214 rdf:type schema:CreativeWork
215 sg:pub.10.1038/clpt.1986.35 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052298210
216 https://doi.org/10.1038/clpt.1986.35
217 rdf:type schema:CreativeWork
218 sg:pub.10.1038/clpt.1987.107 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042716098
219 https://doi.org/10.1038/clpt.1987.107
220 rdf:type schema:CreativeWork
221 sg:pub.10.2165/00003088-198106060-00002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024854213
222 https://doi.org/10.2165/00003088-198106060-00002
223 rdf:type schema:CreativeWork
224 grid-institutes:None schema:alternateName Unité de Pharmacologie Clinique, Lyon, France
225 schema:name INSERM, Lyon, France
226 Unité de Pharmacologie Clinique, Lyon, France
227 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...